The "Mar-A-Lago Accord" Is Now Underway

The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)

AstraZeneca's Fasenra Falls Short In Smoker's Lung Trial

Vandana Singh
September 17, 2025

AstraZeneca Plc (NASDAQ:AZN) released on Wednesday topline data from RESOLUTE Phase 3 trial of Fasenra (benralizumab).

AZN is showing upward bias. Get the complete picture here.

Fasenra, despite showing numerical improvement, did not achieve statistical significance in the primary endpoint in patients with chronic obstructive pulmonary disease (COPD), also known as smoker’s lung disease.

The safety and tolerability profile for Fasenra in the trial was consistent with the known profile of the medicine.

The company will analyse the full data set from RESOLUTE.

Fasenra is currently approved as an add-on maintenance treatment for severe eosinophilic asthma (SEA) in more than 80 countries, including the US, Japan, the EU, and China.

It is also approved for SEA in children and adolescents aged six and above in the U.S. and Japan.

Fasenra has also been approved in more than 60 countries for the adult treatment of eosinophilic granulomatosis with polyangiitis, and it is under regulatory review for the treatment of hypereosinophilic syndrome.

AstraZeneca also shared high-level results from a pre-specified interim analysis of the Phase 3 TULIP-SC trial in patients with systemic lupus erythematosus (SLE).

The trial showed the subcutaneous (SC) administration of AstraZeneca's Saphnelo (anifrolumab) demonstrated a statistically significant and clinically meaningful reduction in disease activity compared to placebo.

Also Read: Regeneron, Sanofi Stock Falls After Uneven Smoker’s Lung Drug Data

The safety profile observed in the interim analysis was consistent with the known clinical profile of Saphnelo administered as an intravenous (IV) infusion.

The reduction in disease activity in TULIP-SC was measured using the British Isles Lupus Assessment Group-based Composite Lupus Assessment (BICLA) at week 52.

The BICLA requires improvement in all organs with disease activity at baseline, with no new flares.

The TULIP-SC interim results are under regulatory review.

Saphnelo IV infusion is approved for moderate to severe SLE in more than 70 countries.

AZN Price Action: AZN stock is up 0.11% at $77.64 at the publication on Wednesday.

Read Next:

  • Broadcom Expands Lloyds Banking Deal To Power Massive Digital Overhaul

Photo by Piotr Swat via Shutterstock

Continue Reading...

Popular

Cathie Wood Dumps $5.2 Million Worth of This AI Stock, Here's What Ark Bought Instead

Ark Invest decided to sell shares of Tempus AI (TEM), despite positive news of FDA clearance for its diagnostic device. They also made other key trades.

3 Gold Mining Stocks Shine As Prices Hit Records

Gold mining stocks Anglogold Ashanti, Coeur Mining, and New Gold join the top 10% for quality as gold prices hit fresh highs.

Margins Built for Scale - Ad

90%+ gross margins. Subscription potential. Facility ready to produce.

Reactions pour in about ABC's suspension of Jimmy Kimmel's show

ABC's following comments he made about the set off a flood of reactions, including from President Donald Trump and a fellow late-night host after he criticized a deal between the Trump administration and his own network's parent company.

Timing the Next Health Trend - Ad

Every wave begins small. This one is forming now with first-mover advantage in peptide delivery.

Move over, green lawns. Drier, warmer climate boosts interest in low-water landscaping

LITTLETON, Colo. (AP) — When Lena Astilli first bought her home outside of Denver, she had no interest in matching the wall-to-wall green lawns that dominated her block. She wanted native plants — the kind she remembered and loved as a child in New Mexico, that require far less water and have far more to offer insects and birds that are in decline.

Bitcoin Taps $117,000, Ethereum, XRP, Dogecoin Shine On Federal Reserve Rate Cut

Cryptocurrency markets rallied on Thursday morning after the Federal Reserve delivered its anticipated 25-basis point rate cut, lifting risk sentiment across digital assets

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

SWIFT Taps Ethereum Layer-2 Chain Linea, Bitcoin's Fall, Mark Cuban's Bitcoin ETF Observation And More: This Week In Crypto

It’s been quite a week in the world of cryptocurrency. From SWIFT’s decision to use Ethereum’s Layer-2 blockchain for stablecoin testing to Bitcoin’s price drop, here’s a quick recap of the top stories from the weekend.

Spirit Airlines to furlough 1,800 flight attendants amid second bankruptcy

Spirit Airlines plans to furlough 1,800 flight attendants before the end of the year, the cash-strapped budget carrier said Monday.

History's Playbook Repeats - Ad

Novo, Lilly, Rhythm... each started small. This Canadian peer could follow with needleless peptide delivery.

Workday Stock Jumps After Activist Investor Reveals $2 Billion Stake

Shares of Workday Inc. (NASDAQ:WDAY) are rising Wednesday after activist investor Elliott Investment Management revealed a $2 billion stake in the human resources technology firm, signaling strong confidence in recent moves.

How 4 key infrastructure projects centered in Italy will reshape the European travel map

MILAN (AP) — Workers will begin drilling and blasting open the first tunnel connecting Austria to Italy under the Brenner Pass through the Alps on Thursday, marking a major milestone in a series of ambitious European Union projects that will accelerate passenger train travel between metropolitan centers and shift freight off the roads and onto rails.

October 16: D-Day For The Dollar - Ad

A quiet shift in U.S. law has just authorized private companies to mint a new form of government-authorized money called the "Dollar 2.0"... and the next major mint hits on October 16. Investors who make the right moves before then could make up to 40X by 2032...

Will Alibaba's New Chip Finally Unseat Nvidia In China?

Alibaba debuts a powerful new chip and an efficient, open-source AI agent, directly challenging Nvidia and OpenAI.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Co-Diagnostics Stock Plunges 28% In Pre-Market Despite Strategic Saudi Partnership

Co-Diagnostics (CODX) shares dropped 24.87% in pre-market trading after an 80.76% surge, despite announcing a strategic partnership.

Bank of New York Mellon Stock: A Deep Dive Into Analyst Perspectives (8 Ratings)

Bank of New York Mellon (NYSE: BK) underwent analysis by 8 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.

Why Are Wall Street Insiders Moving Their Money to This One Asset? - Ad

Something far more consequential for your money than tariffs is unfolding behind the scenes... Tucked inside this overlooked directive is a plan set to be executed for the first time in in U.S. history. One Stansberry Research's Senior Partner says it's set to trigger a rare window for potentially explosive gains in ONE asset immediately. (Not AI or crypto). Wall Street insiders are already positioning themselves... and he insists you should, too, before it's too late.

AquaBounty Technologies Stock Explodes Over 98% After Hours: Here's Why

AquaBounty Technologies saw a massive 98.25% surge in after-hours trading to $2.26, following confirmation that it had met NASDAQ's minimum bid price requirement, resolving its earlier delisting risk.

A drug made from marijuana reduced back pain in a large study

WASHINGTON (AP) — An experimental medication made from successfully reduced back pain in a new study, offering further support for the drug’s potential in treating one of the most common forms of .

Electric Bills Keep Rising - Ad

Since 2024, US power costs jumped 6.5%, and analysts warn another 8% nationwide rise by 2030. One small US stock could benefit as more households turn to backup storage.

Cadillac F1 team announces multi-year partnership with Jim Beam

The new Cadillac F1 team on Wednesday announced a multi-year that makes the American bourbon distiller its official spirits partner.

Trump's touting of an unproven autism drug surprised many, including the doctor who proposed it

WASHINGTON (AP) — When President Donald Trump's administration announced it would as a new treatment for autism, it came as — including the physician who suggested the idea to the nation’s top health officials.

Celebrity Demand Meets Mass Adoption - Ad

Some stars already use them. Now the door is opening for everyone else.

Trump's Social Security Chief Walks Back Stunning Comment On Raising Retirement Age After Backlash, Says Will 'Never Cut' Benefits

Social Security Commissioner Frank Bisignano reversed comments suggesting the Trump administration was considering raising the retirement age, clarifying that it is not under consideration.

Trump asks the Supreme Court for an emergency order to remove Lisa Cook from the Fed board

WASHINGTON (AP) — The Trump administration on Thursday asked for an emergency order to remove from the Federal Reserve’s board of governors.

The "Mar-A-Lago Accord" Is Now Underway - Ad

The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)

Indonesia's clean energy future is at the center of a supply struggle between the US and China

The race to replace coal in Indonesia, the world’s largest coal exporter, has become a contest between the U.S. and China. At stake is not only Indonesia’s climate future, but also which superpower sets the terms for the next generation of energy in the developing world.

India expresses concern about Trump plan to hike fees on H-1B visas that bring tech workers to US

WASHINGTON (AP) — The Indian government expressed concern Saturday about President Donald Trump's latest push to upend American immigration policy, dramatically raising the fee for visas that bring tech workers from India and other countries to the United States.

Margins Built for Scale - Ad

90%+ gross margins. Subscription potential. Facility ready to produce.

US To Set $5 Billion Critical Minerals Fund

US to launch $5 billion fund for critical minerals, in partnership with Orion Resource Partners and other investors. Aimed at reducing reliance on Chinese supply chains and securing long-term resources.

Timing the Next Health Trend - Ad

Every wave begins small. This one is forming now with first-mover advantage in peptide delivery.

Kevin O'Leary Once Admitted He Wasn't The Best Dad — But The Shark Gave Himself A '10 Out Of 10' Score In One Key Area

Kevin O'Leary admitted he wasn't always present as a father but said financial stability made him a "10 out of 10" provider, sharing how tough-love lessons with his son and sacrifices echoed by Barack Obama and Mark Cuban highlight the trade-offs between family and success.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session

Gainers Robo.ai (NASDAQ: AIIO) shares rose 30.0% to $2.64 during Thursday's regular session. The market value of their outstanding shares is at $685.3 million.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright systemtrading.ca
Privacy Policy | Terms of Service